Latest news
From Medicines to Markets: Understanding AFT Pharmaceuticals’ (ASX:AFP) Place in Healthcare - KalkineKalkine · Fri, 07 Aug 2026 02:52:00 GMTAFT Pharmaceuticals: Surfing the wave of investor optimism pushes - BusinessDesk | NZBusinessDesk | NZ · Mon, 03 Aug 2026 17:00:00 GMTSmall NZ drugmaker quietly outperforms global giants Pfizer and Merck - NewsroomNewsroom · Sun, 02 Aug 2026 17:00:00 GMTAFT Pharmaceuticals Chair David Flacks to Step Down Within a Year as Revenue Surges to $254.7 Million - Kalkine MediaKalkine Media · Fri, 31 Jul 2026 07:00:00 GMTAFT Pharmaceuticals Shareholders Re-Elect Marree Atkinson With 99.98% Support at 2026 Annual Meeting - KalkineKalkine · Fri, 31 Jul 2026 07:00:00 GMTAFT Pharmaceuticals Re-Elects Director Marree Atkinson with 99.98% Vote at 2026 AGM - Kalkine MediaKalkine Media · Fri, 31 Jul 2026 07:00:00 GMTAFT Pharmaceuticals Reports 22% Revenue Growth to $254.7 Million, Lifts Dividend to 2.5 Cents - KalkineKalkine · Fri, 31 Jul 2026 07:00:00 GMTAFT Pharmaceuticals Chair David Flacks to Retire Within 12 Months as Revenue Hits $254.7 Million - KalkineKalkine · Fri, 31 Jul 2026 07:00:00 GMT